https://www.coagulomed.com/clinical-and-scientific-advisors daily 0.75 2025-06-30 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607959083-CS4V5JQGS6UQ9U5FIFWO/Slide6.JPG Clinical and Scientific Advisors William Gormley, MD, MPH, MBA Dr. Gormley is a neurosurgeon and critical care physician with 30 years of direct medical experience. Dr. Gormley currently serves as Director of Neurosurgical Critical Care at the Brigham and Women’s Hospital, Surgical Director for Neuroscience Intensive Care at Dana-Farber’s Center for Neuro-Oncology and Associate Professor of Neurosurgery at Harvard Medical School. Dr. Gormley earned an MD from the Autonomous University of Guadalajara, an MBA from MIT Sloan School of Management and an MPH from the Harvard TH Chan School of Public Health. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607964481-Z7LWLCQ1N6K2Y0V0B6OQ/Slide15.JPG Clinical and Scientific Advisors Elizabeth Van Cott, MD Dr. Van Cott is the Director of the Coagulation Laboratory and Medical Director of the Core Laboratory at the Massachusetts General Hospital. Dr. Van Cott also holds an appointment as a Professor of Pathology at Harvard Medical School. Dr. Van Cott has served as the President of the North American Specialized Coagulation Laboratory Association (NASCOLA) and is an advisor to the Committee on Hematology for the CLSI. Dr. Van Cott earned her MD from Harvard Medical School and completed her residency in Clinical Pathology at MGH. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/3ee37c4d-0250-400a-96c5-3bea3e97d02d/Slide3-3.JPG Clinical and Scientific Advisors - Make it stand out Frank LaDuca, PhD, FAHA Dr. LaDuca has 30 years of experience developing and commercializing in vitro diagnostics, including for coagulation testing. Dr. LaDuca previously served as the CTO of Coagulo, the CSO of Accriva Diagnostics, ITC and PTS as well as the VP of Quality Systems at Siemens Diagnostics and the Senior Director of Global Regulatory & Compliance at Bayer Diagnostics. Dr. LaDuca is the past Chair of the AACC Critical Point-of-Care Division and past Chair of the CLSI for Point-of-Care Testing. Dr. LaDuca completed fellowships at Johns Hopkins Hospital and earned a MS and PhD from SUNY-Buffalo and a BS from SUNY-Albany. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/4097f2da-785f-408f-8263-26271e473db8/EB.jpg Clinical and Scientific Advisors - Make it stand out Edward Boyer, MD, PhD Dr. Boyer is a Visiting Professor at the Ohio State University College of Medicine. He also holds the position of Assistant in Medicine in the Department of Pediatrics at Boston Children’s Hospital. Additionally, he is a Professor of Emergency Medicine at the Brigham and Women’s Hospital. Dr. Boyer completed his graduate and Medical school training at Columbia University College of Physicians & Surgeons, completed an internship at the Medical College of Pennsylvania Hospital and then completed his residency and fellowships at the University of PA Medical Center Presbyterian and Boston Children’s Hospital. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1575996810481-8BSOF55HWIKKOQ6O137R/peacock+image.jpg Clinical and Scientific Advisors Frank Peacock, MD, FACEP, FACC Dr. Peacock is a Professor of Emergency Medicine, Associate Chair and Research Director for the Dept. of Emergency Medicine at the Baylor College of Medicine. He is a member of the Accreditation Management Board for the American College of Cardiology and the NCDR Action Registry-Get With the Guidelines Research and Publications Committee. Dr. Peacock received his MD from Wayne State University and completed his Emergency Medicine training at William Beaumont Hospital. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607970755-UJRSN27BTUURKOC3RUKJ/Slide11.JPG Clinical and Scientific Advisors Michael Streiff, MD Dr. Streiff is the Medical Director of the Johns Hopkins Hospital Special Coagulation Laboratory and the Anticoagulation Management Service and Outpatient Clinic. Dr. Streiff is also an Attending Physician at the Comprehensive Hemophilia Treatment Center and is a Professor of Medicine. He specializes in coagulation disorders, hemophilia, medical oncology and VTE. Dr. Streiff earned an MD from Johns Hopkins University and completed fellowships in Medicine, Hematology and Oncology at the Johns Hopkins Hospital. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/478f0a7f-fc25-4011-a516-3128a62c58fb/DK.jpg Clinical and Scientific Advisors - Make it stand out David King, MD, FACS, DABS Dr. King is a Trauma and Acute Care Surgeon at the Massachusetts General Hospital. He is also a Colonel in the US Army within the special operations community with multiple combat deployments. Additionally, Dr. King holds the position of Associate Professor of Surgery at Harvard Medical School. Dr. King received his MD from the University of Miami School of Medicine and subsequently completed his residency and fellowships at Beth Israel Deaconess Medical Center and Jackson Memorial Hospital/University of Miami. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/7a1c54b7-b4c6-46c1-b8be-ddf763872bbf/jc.jpg Clinical and Scientific Advisors Jean Connors, MD Dr. Connors is the Medical Director, Hemostatic Antithrombotic Stewardship program and Anticoagulation Management Service at the Brigham and Women’s Hospital/Dana-Farber Cancer Institute. She also holds the position of Associate Professor of Medicine at Harvard Medical School. Dr. Connors received his MD from Johns Hopkins School of Medicine and completed her residency and fellowships at Beth Israel Hospital and the Brigham and Women’s Hospital. https://www.coagulomed.com/leadership daily 0.75 2025-06-30 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574530543934-8PSQQPS9YQU6XEBB44RZ/Slide2.JPG Leadership Marcia Zucker, PhD Head of Regulatory Affairs Dr. Zucker is an expert in medical diagnostics, specializing in coagulation. Dr. Zucker is a fellow of the AACC, where she has served as Chair of the Critical and Point-of-Care Testing Division, and is a member of the CLSI for Point-of-Care Testing. Previously, Dr. Zucker was the Director of Clinical Research at ITC, where she focused on point-of-care in vitro diagnostics and led teams in clinical, regulatory, marketing, QA and sales as well as risk assessment activities (FMEA) and acting as the “voice of the customer” on new product development. Dr. Zucker earned her PhD in Molecular Biology from Princeton University and her BS in Biology from Rennselaer Polytechnic Institute. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574530513086-N6X59JZ1FWJCV5ZHANG5/Slide13.JPG Leadership Jarrod Niebloom, JD President and Executive Chairman Mr. Niebloom is the Managing Partner and Executive Chairman of Meadowbrook Capital, LLC, and was formerly the CEO of Coagulo. Previously, he was a faculty member at the Harvard Law School and advised global corporations, federal and state government officials and other high-profile clients on a range of constitutional and complex legal matters, including antitrust, various aspects of federal justiciability doctrine, preemption and a host of federal statutory and administrative issues. He has worked with litigants and counsel in cases before the U.S. Supreme Court and has authored the law treatise, Constitutional Principles, Antitrust Theory. Mr. Niebloom earned a JD from Harvard Law School, and a BA in Quantitative Economics and Political Theory from Tufts University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/091bcd7f-c297-471a-bec9-6e4b215bd91f/Slide4-2.JPG Leadership Barry Berger, MD, FCAP Chief Medical Officer Dr. Berger served as CMO at Exact Sciences Corp. for over 20 years, where he was responsible for key strategic collaborations with academic, research, clinical, political, medical, professional and patient advocacy groups and spearheaded regulatory and reimbursement strategy. Before joining Exact, Dr. Berger was the Chair of Pathology and Laboratory Medicine at Harvard Pilgrim Healthcare, Associate Director of Pathology and Laboratory Medicine at Harvard Community Health Plan and a faculty member in Pathology at Harvard Medical School. Dr. Berger completed his residency in Pathology at Brigham and Women’s Hospital and received his MD from UPenn and his BS in Biology from the University of Miami. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574530500886-UA5N7T2DLWXUABOCON9I/Slide1.JPG Leadership Galit Frydman, DVM, ScD Chief Science Officer Dr. Frydman holds positions in the Division of Trauma, Emergency Surgery and Surgical Critical Care at the Massachusetts General Hospital and in the Center for Biomedical Engineering at the Massachusetts Institute of Technology, where she specializes in coagulopathies and immunothrombosis. Dr. Frydman has completed several fellowships at MIT, HMS and MGH, where she developed Coagulo’s platform technology. She has published numerous papers and book chapters on coagulation, platelet physiology, immunothrombosis and stem cell biology. Dr. Frydman earned a ScD in Biological Engineering from MIT, a DVM from the University of Florida, and a BS in Biology from Carnegie Mellon University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/d5cd1cae-1959-4361-941c-1e54b809dcf6/Brett.jpg Leadership Brett Giffin, MBA Chief Executive Officer Mr. Giffin has more than 30 years of executive experience leading and managing healthcare companies ranging from venture-backed start-ups to global market leaders in coagulation diagnostics, including having served as Chief Commercial Officer of T2 Biosystems, CEO of Fibronostics, President and CEO of 3si Systems and Chief Commercial Officer of Accriva Diagnostics (now Werfen). Previously, he held various sales, marketing and business development roles at Drager Medical, Mallinckrodt (Medtronic), Boston Scientific and Johnson & Johnson. Mr. Giffin began his career as an U.S. Army officer serving in combat unit leadership roles throughout Central America. He holds an MBA from University of Phoenix and a BA from the College of William & Mary, where he was also a Distinguished Military Graduate. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574702678066-XAEOMP390UVCGLUT08AV/Slide1.JPG Leadership https://www.coagulomed.com/contact-1 daily 0.75 2019-11-23 https://www.coagulomed.com/board-of-directors daily 0.75 2025-06-30 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574606316280-A8EHYGZYEKJBE4H9OLIV/Slide13.JPG Board of Directors Jarrod Niebloom, JD Executive Chairman Mr. Niebloom is the Managing Partner and Executive Chairman of Meadowbrook Capital, LLC, and was formerly the CEO of Coagulo. Previously, he was a faculty member at the Harvard Law School and advised global corporations, federal and state government officials and other high-profile clients on a range of constitutional and complex legal matters, including antitrust, various aspects of federal justiciability doctrine, preemption and a host of federal statutory and administrative issues. He has worked with litigants and counsel in cases before the U.S. Supreme Court and has authored the law treatise, Constitutional Principles, Antitrust Theory. Mr. Niebloom earned a JD from Harvard Law School, and a BA in Quantitative Economics and Political Theory from Tufts University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/6c942b24-7651-4e9b-88fe-bea76858a8a2/Sperzel+Headshot.jpg Board of Directors John Sperzel Independent Director Mr. Sperzel has served as Chairman and CEO of T2 Biosystems, CEO of Chembio Diagnostics, CEO of Accriva Diagnostics (acquired by Werfen), and President of Axis-Shield (acquired by Alere/Abbott). Earlier in his career, he held senior leadership roles at Bayer Diagnostics (acquired by Siemens), IL/Werfen, and Boehringer Mannheim (acquired by Roche). Mr. Sperzel also serves on the Board of Directors for the U.S. Organ Procurement and Transplantation Network (OPTN), under the U.S. Department of Health and Human Services. He earned a Bachelor of Science degree from Plymouth State University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/ca0aaf27-24b8-406e-94e6-a62c4e88961d/MM.jfif.jpeg Board of Directors - Make it stand out Martin Madaus, PhD Director Emeritus Dr. Madaus is an Operating Executive at the Carlyle Group. Dr. Madaus has previously served as CEO of Roche Diagnostics (North America), Chairman and CEO of Ortho Clinical Diagnostics, President, Chairman and CEO of Millipore Corporation (acquired by Merck) and Lead Director of Quanterix. He earned a Doctor of Veterinary Medicine from the University of Munich, Germany, and a PhD in Veterinary Medicine from the Veterinary University of Hannover, Germany. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574530894123-X5R3U6Q6XAGB0UA4VKY8/Slide9.JPG Board of Directors Derek Lee Director Mr. Lee is the founder and managing director of DHL Ventures LLC, and senior advisor at Athyrium Capital Management LP. Mr. Lee has co-founded, invested in and advised companies across biotechnology, medical devices and healthcare services, and previously served as founder, CFO and CDO of Talaris Advisors, a senior analyst at Burrage Capital, a principal at SV Life Sciences, and held investment banking positions in the Global Healthcare Group at UBS Warburg and in the Healthcare Investment Banking Group at Salomon Smith Barney. Mr. Lee earned a BS in Finance, Accounting and Economics from Bentley University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574530880503-WDRWHF5CD2JFES2XQ7ZK/Slide8.JPG Board of Directors Susan Volkert, JD, LLM Independent Director Ms. Volkert is currently a litigation Partner at DeCoitis, FitzPatrick & Cole, LLP, and previously served as Chief Compliance Officer, Vice President and Deputy General Counsel of Hoescht Celanese (Sanofi Aventis). Ms. Volkert served as the Deputy Chief of the Torts and Commercial Litigation Branches of the U.S. Department of Justice in Washington, D.C., and as the Deputy Chief of the Civil Division of the the U.S. Attorney’s Office for the District of New Jersey. Ms. Volkert is a graduate of UPenn and the University of Toledo Law School and holds an LLM in Health Law from Seton Hall University School of Law. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574606334079-YVRGOAY1MT6TKNXUWC3V/Slide1.JPG Board of Directors Galit Frydman, DVM, ScD Director Dr. Frydman holds positions in the Division of Trauma, Emergency Surgery and Surgical Critical Care at the Massachusetts General Hospital and in the Center for Biomedical Engineering at the Massachusetts Institute of Technology, where she specializes in coagulopathies and immunothrombosis. Dr. Frydman has completed several fellowships at MIT, HMS and MGH, where she developed Coagulo’s platform technology. She has published numerous papers and book chapters on coagulation, platelet physiology, immunothrombosis and stem cell biology. Dr. Frydman earned a ScD in Biological Engineering from MIT, a DVM from the University of Florida, and a BS in Biology from Carnegie Mellon University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1604851341192-R9F02VV1SVMR8BSIPNLP/hillel.jpg Board of Directors Hillel Bachrach, MBA Director Mr. Bachrach is the Managing Partner and Executive Chairman of 20/20 HealthCare Partners LLC. Previously, Mr. Bachrach served as the Executive Chairman of Viztek (acquired by Konica Minolta in 2015), President of Odin Medical Technologies (acquired by Medtronic in 2006), President and CEO of OREX Computed Radiography (acquired by Kodak in 2005), helped found UltraSPECT, co-founded MSq (now Alma Lasers, acquired by Fosun Pharma) and co-founded and served as the Executive Vice President and Vice Chairman of ESC Medical Systems (public in 1996, now Lumenis). Mr. Bachrach holds an MBA from Northwestern University’s J.L. Kellogg Graduate School of Management and a BS in Electronic Engineering from the Technion Israeli Institute of Technology. https://www.coagulomed.com/autoimmune-cancer-and-infectious-disease daily 0.75 2019-11-24 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574526548554-HNGWJNHD8SOUEQZWCUI1/shutterstock_727337434.jpg Autoimmune, Cancer and Infectious Disease https://www.coagulomed.com/the-future daily 0.75 2019-11-25 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574526861974-UPW7Y1XWX8EGFVXRCEET/shutterstock_1011621754.jpg The Future https://www.coagulomed.com/anticoagulant-management daily 0.75 2019-11-25 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574527919713-4RK6GHKGF3CAM3H8VN5R/shutterstock_326842199.jpg Anticoagulant Management https://www.coagulomed.com/news daily 0.75 2023-06-09 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574528650326-ZBBY5OUSFSRTRTP02M6Q/mic+2.jpg News https://www.coagulomed.com/business-and-strategic-advisors daily 0.75 2025-06-30 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607718879-1E4Z1IX5WVDNSJCBCLA6/Slide9.JPG Strategic Advisors Derek Lee Mr. Lee is the founder and managing director of DHL Ventures LLC, and senior advisor at Athyrium Capital Management LP. Mr. Lee has co-founded, invested in and advised companies across biotechnology, medical devices and healthcare services, and previously served as founder, CFO and CDO of Talaris Advisors, a senior analyst at Burrage Capital, a principal at SV Life Sciences and held investment banking positions in the Global Healthcare Group at UBS Warburg and in the Healthcare Investment Banking Group at Salomon Smith Barney. Mr. Lee earned a BS in Finance, Accounting and Economics from Bentley University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/bf8527ca-b82c-4697-8791-951c61b1def7/MM.jfif.jpeg Strategic Advisors Martin Madaus, PhD Dr. Madaus is an Operating Executive at the Carlyle Group. Dr. Madaus has previously served as CEO of Roche Diagnostics (North America), Chairman and CEO of Ortho Clinical Diagnostics, President, Chairman and CEO of Millipore Corporation (acquired by Merck) and Lead Director of Quanterix. He earned a Doctor of Veterinary Medicine from the University of Munich, Germany, and a PhD in Veterinary Medicine from the Veterinary University of Hannover, Germany. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607713916-05JTDEZYU7XN9KNKM493/Slide7.JPG Strategic Advisors Shawn Marcell Mr. Marcell has over 25 years of experience co-founding, chairing and leading the growth of numerous venture-backed companies in the life sciences, including ReedCoor, MetaMark Genetics (acquired by P4 Diagnostix in 2016), SensiGen (acquired by Sequenom in 2013), Lifecodes (division of Hologic, acquired by Immucor in 2009), and RedPoint Bio (public in 2005). Mr. Marcell earned a BA in Economics from George Washington University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/4f2b618f-6e45-4f1b-856c-67e074f99089/DZ.jfif Strategic Advisors Dan Zabrowski, PhD Dr. Zabrowksi worked for over 20 years at Roche, where he oversaw over 300 acquisition and partnership deals and held a number of key global leadership positions, including President of Ventana Medical Systems, Global Head of Regulatory Affairs, Global Head of Development Operations, Global Head of Roche Pharma Partnering and President of the Roche Sequencing Unit. Dr. Zabrowski has previously served as a member of Roche’s Enlarged Corporate Executive Committee and as a director of Chugai Pharmaceuticals. Dr. Zabrowski received his PhD in Organic Chemistry from Indiana University, Bloomington and his BA in Chemistry from Saint Louis University. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574607703559-Q129WTY9G3GXQGHRYSMC/Slide10.JPG Strategic Advisors Hillel Bachrach, MBA Mr. Bachrach is the Managing Partner and Executive Chairman of 20/20 HealthCare Partners LLC. Previously, Mr. Bachrach served as the Executive Chairman of Viztek (acquired by Konica Minolta in 2015), President of Odin Medical Technologies (acquired by Medtronic in 2006), President and CEO of OREX Computed Radiography (acquired by Kodak in 2005), helped found UltraSPECT, co-founded MSq (now Alma Lasers, acquired by Fosun Pharma) and co-founded and served as the Executive Vice President and Vice Chairman of ESC Medical Systems (public in 1996, now Lumenis). Mr. Bachrach holds an MBA from Northwestern University’s J.L. Kellogg Graduate School of Management and a BS in Electronic Engineering from the Technion Israeli Institute of Technology. https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574868722123-GXZ52AJ3SD8OMZNW8Q0Y/volkert.jpg Strategic Advisors Susan Volkert, JD, LLM Ms. Volkert is currently a litigation Partner at DeCoitis, FitzPatrick & Cole, LLP, and previously served as Chief Compliance Officer, Vice President and Deputy General Counsel of Hoescht Celanese (Sanofi Aventis). Ms. Volkert served as the Deputy Chief of the Torts and Commercial Litigation Branches of the U.S. Department of Justice in Washington, D.C., and as the Deputy Chief of the Civil Division of the the U.S. Attorney’s Office for the District of New Jersey. Ms. Volkert is a graduate of UPenn and the University of Toledo Law School and holds an LLM in Health Law from Seton Hall University School of Law. https://www.coagulomed.com/home daily 1.0 2019-11-25 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574523956166-T49WZ6P5IZTNLDBNL2AK/shutterstock_451343992.jpg Home https://www.coagulomed.com/about daily 0.75 2023-06-24 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574525168525-8A3QQZ36FOW3C80XGJ87/shutterstock_1011621754.jpg About https://www.coagulomed.com/pediatric-medicine daily 0.75 2023-06-24 https://images.squarespace-cdn.com/content/v1/5dd94901782768313a305c1d/1574526311846-0OSWWP3OS6ZJX5RDID1Q/shutterstock_1049865191.jpg Pediatric Medicine https://www.coagulomed.com/home-alt-bedford daily 0.75 2025-05-12 https://images.squarespace-cdn.com/content/v1/52a74d9ae4b0253945d2aee9/1390500612440-PGQSIY8KL9F7T5VIXQLO/chambers-2.jpg Home Alt A better world Starts with a choice Contact Us https://images.squarespace-cdn.com/content/v1/52a74d9ae4b0253945d2aee9/1390500503574-5BAPXZO9U06UV61P49UO/chambers1.jpg Home Alt Sustainability Starts with you Join Us https://images.squarespace-cdn.com/content/v1/52a74d9ae4b0253945d2aee9/1390500933384-LII4SRIPHFYOUFX0UCXC/chambers-4.jpg Home Alt A better world Starts with a choice Join Us https://images.squarespace-cdn.com/content/v1/52a74d9ae4b0253945d2aee9/1390504287124-HQ8GNX1JCE22V047MSQ9/chambers-8.jpg Home Alt Preserve Nature Join Us